Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001366151 | SCV001562446 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2021-02-08 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with CNTNAP2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is present in population databases (rs764014323, ExAC 0.006%). This sequence change replaces arginine with tryptophan at codon 286 of the CNTNAP2 protein (p.Arg286Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. |
Gene |
RCV001587378 | SCV001824149 | uncertain significance | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |